The Use of AlloMap and AlloSure in Combined Heart-Kidney Transplantation
Kidney disease is a common comorbidity seen in heart disease, and so the number of patients undergoing combined heart-kidney transplantation (HKT) continues to increase, as well as the number of waitlisted patients for HKT. Recent evidence suggests a favorable immunomodulatory effect for combined HKT, making these patients ideal candidates for non-invasive monitoring for rejection and injury. The use of gene-expression profile testing (AlloMap ®) in HKT recipients vs heat transplant (HT) alone has remained uncertain with earlier reports suggesting higher values in HKT, while more recent reports suggesting equivocal results between the two.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: E.C. DePasquale, M. Deng, M. Kamath, S. Hall Tags: (705) Source Type: research
More News: Cardiology | Genetics | Heart | Heart Disease | Heart Transplant | Kidney Transplant | Kidney Transplantation | Lung Transplant | Transplant Surgery | Transplants | Urology & Nephrology